Is tonsillectomy indicated in IgA-nephropathy?


Cite item

Full Text

Abstract

Indications and efficacy of tonsillectomy in IgA-nephropathy are discussed.

About the authors

- -

References

  1. Tumlin J.A., Madaio M.P., Hennigar R. Idiopathic IgA-nephropathy: pathogenesis, histopathology and therapeutic options. Clin. J. Am. Soc. Nephrol. 2007; 2: 1054 - 1061
  2. Itoh A., Iwase H., Takatani T. et al. Tonsillar IgA1 as a possible source of hypoglycosylated IgA1 in the serum of IgA nephropathy patients. Nephrol. Dial. Transplant. 2003; 18(6): 1108-1114
  3. Yamabe H., Sugawara T., Nakamura M., Shimada M. Involvement of tonsils in IgA nephropathy. Acta Otolaryngol. Suppl. 2004; 555: 54-57
  4. Kusakari C., Nose M., Takasaka T. et al. Immunopathological features of palatine tonsil characteristic of IgA nephropathy: IgA1 localization in follicular dendritic cells. Clin. Exp. Immunol. 1994; 95(1): 42-48
  5. Itoh A., Iwase H., Takatani T. et al. Disordered balance of IgA subclass production in the tonsils of some IgA nephropathy patients. J. Nephrol. 2005; 18(5): 575-581
  6. Matsuda M., Shikata K., Wada J. et al. Increased urinary excretion of macrophage-colony-stimulating factor (M-CSF) in patients with IgA nephropathy: tonsil stimulation enhances urinary M-CSF excretion. Nephron. 1999; 81(3): 264-270
  7. Kanamoto Y., Shibata R., Ozono Y., Harada T. Effect of tonsillectomy on peripheral blood T cell surface markers and cytokine production in patients with IgA nephropathy accompanied by chronic tonsillitis. Nippon Jinzo Gakkai Shi. 1994; 36(11): 1296-1302
  8. Xie Y., Chen X., Nishi S. et al. Relationship between tonsils and IgA nephropathy as well as indications of tonsillectomy. Kidney Int. 2004; 65(4): 1135-1144
  9. Sugiyama N., Shimizu J., Nakamura M. et al. Clinicopathological study of the effectiveness of tonsillectomy in IgA nephropathy accompanied by chronic tonsillitis. Acta Otolaryngol. Suppl. 1993; 508: 43-48
  10. Nishi S., Xie Y., Ueno M. et al. A clinicopathological study on the long-term efficacy of tonsillectomy in patients with IgA nephropathy. Acta Otolaryngol. Suppl. 2004;555: 49-53
  11. Akagi H., Nishizaki K., Hattori K. et al. Prognosis of tonsillectomy in patients with IgA nephropathy. Acta Otolaryngol. Suppl. 1999; 540: 64-66
  12. Tomioka S., Miyoshi K., Tabata K. et al. Clinical study of chronic tonsillitis with IgA nephropathy treated by tonsillectomy. Acta Otolaryngol. Suppl. 1996; 523: 175-177.
  13. Sanai A, Kudoh F. Effects of tonsillectomy in children with IgA nephropathy, purpura nephritis, or other chronic glomerulonephritides. Acta Otolaryngol. Suppl. 1996; 523: 172-174
  14. Hotta O., Miyazaki M., Furuta T. et al. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am. J. Kidney Dis. 2001; 38(4): 736-743
  15. Suwabe T., Ubara Y., Sogawa Y. et al. Tonsillectomy and corticosteroid therapy with concomitant methylprednisolone pulse therapy for IgA nephropathy. Contrib. Nephrol. 2007; 157: 99-103
  16. Suwabe T., Ubara Y., Sogawa Y. et al. Tonsillectomy and corticosteroid therapy with concomitant methylprednisolone pulse therapy for IgA nephropathy. Contrib. Nephrol. 2007; 157: 99-103
  17. Sato M., Hotta O., Tomioka S. et al. Cohort study of advanced IgA nephropathy: efficacy and limitations of corticosteroids with tonsillectomy. Nephron Clin. Pract. 2003; 93(4): c137-c145
  18. Komatsu H., Fujimoto S., Hara S. et al. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy. Ren. Fail. 2005; 27(1): 45-52
  19. Kawasaki Y., Suyama K., Abe Y. et al. Tonsillectomy with methylprednisolone pulse therapy as rescue treatment for steroid-resistant IgA nephropathy in children. Tohoku J. Exp. Med. 2009; 218(1): 11-16
  20. Piccoli A., Codognotto M., Tabbi M.G. et al. Influence of tonsillectomy on the progression of mesangioproliferative glomerulonephritis. Nephrol. Dial. Transplant. 2010 [Epub ahead of print]
  21. Kawamura T. Treatment of IgA-nephropathy: corticosteroids, tonsillectomy and mycophenolat mofetil. Contrib. Nephrol. 2007; 157: 37-43
  22. Fisher M.A., Taylor G.W., Shelton B.J. et al. Periodontal disease and other nontraditional risk factors for CKD. Am. J. Kidney Dis. 2008; 51(1):45-52

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies